53 related articles for article (PubMed ID: 34596255)
1. Effects of oral administration of nonselective Trk inhibitor on bladder overactivity in rodent models of prostatic inflammation.
Igarashi T; Mizoguchi S; Matsuoka K; Kamijo T; Kawano S; Furuta A; Suzuki Y; Kimura T; Pascal LE; Wang Z; Yoshimura N
Prostate; 2024 Aug; 84(11):1016-1024. PubMed ID: 38804836
[TBL] [Abstract][Full Text] [Related]
2. Cross-organ sensitization between the prostate and bladder in an experimental rat model of lipopolysaccharide (LPS)-induced chronic pelvic pain syndrome.
Aydogdu O; Gocun PU; Aronsson P; Carlsson T; Winder M
BMC Urol; 2021 Aug; 21(1):113. PubMed ID: 34419040
[TBL] [Abstract][Full Text] [Related]
3. Transient receptor potential ankyrin 1 channels in the bladder mediate low temperature elicited bladder overactivity in rats.
Imamura T; Ogawa T; Minagawa T; Daimon H; Nagai T; Ueno M; Saito T; Ishizuka O
Neurourol Urodyn; 2024 Jan; 43(1):276-288. PubMed ID: 38010891
[TBL] [Abstract][Full Text] [Related]
4. Qinghua decoction improves chronic nonbacterial prostatitis possibly regulating the chromogranin A/nerve growth factor/tyrosine kinase A signaling pathway mediated by inflammatory factors.
Yunpeng H; Wentao YU; Ying Z; Huazhou XU; Guoxing D; Chaoyi F
J Tradit Chin Med; 2023 Aug; 43(4):695-703. PubMed ID: 37454254
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of KPR-5714, a selective transient receptor potential melastatin 8 antagonist, on chronic psychological stress-induced bladder overactivity in male rats.
Watanabe S; Miyazaki S; Yumoto Y; Kobayashi JI; Fujimori Y
Neurourol Urodyn; 2023 Nov; 42(8):1812-1821. PubMed ID: 37498134
[TBL] [Abstract][Full Text] [Related]
6. Nerve Growth Factor Shows Biphasic Expression during Adjuvant-Induced Neurogenic Inflammation.
Gujar V; Pande RD; Das S
Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612839
[TBL] [Abstract][Full Text] [Related]
7. Water-avoidance stress aggravates prostatic inflammation in a murine model of chronic prostatitis.
Ni J; Ren S; Hu Y; Ma D; Kuang Y; Yoshimura N
Neurourol Urodyn; 2024 Jun; ():. PubMed ID: 38847321
[TBL] [Abstract][Full Text] [Related]
8. Pathophysiology of Overactive Bladder and Pharmacologic Treatments Including β3-Adrenoceptor Agonists -Basic Research Perspectives.
Kwon J; Kim DY; Cho KJ; Hashimoto M; Matsuoka K; Kamijo T; Wang Z; Karnup S; Robertson AM; Tyagi P; Yoshimura N
Int Neurourol J; 2024 Feb; 28(Suppl 1):12-33. PubMed ID: 38461853
[TBL] [Abstract][Full Text] [Related]
9. Autonomic Nervous System Dysfunction Is Related to Chronic Prostatitis/Chronic Pelvic Pain Syndrome.
He H; Luo H; Qian B; Xu H; Zhang G; Zou X; Zou J
World J Mens Health; 2024 Jan; 42(1):1-28. PubMed ID: 37118962
[TBL] [Abstract][Full Text] [Related]
10. Low-Energy Shock Wave Suppresses Prostatic Pain and Inflammation by Modulating Mitochondrial Dynamics Regulators on a Carrageenan-Induced Prostatitis Model in Rats.
Wu ZS; Wang HJ; Lee WC; Luo HL; Lin TK; Chuang YC
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835316
[TBL] [Abstract][Full Text] [Related]
11. The Emerging Role of Cell Adhesion Molecules on Benign Prostatic Hyperplasia.
Liu J; Zhang J; Fu X; Yang S; Li Y; Liu J; DiSanto ME; Chen P; Zhang X
Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769190
[TBL] [Abstract][Full Text] [Related]
12. Radial Extracorporeal Shock Wave Therapy Combined with Resveratrol Derivative Alleviates Chronic Nonbacterial Prostatitis in Rats.
Song Z; Jin C; Bian Z; Liang C
Inflammation; 2023 Apr; 46(2):584-597. PubMed ID: 36434437
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic effects of nerve growth factor-targeting therapy on bladder overactivity in rats with prostatic inflammation.
Igarashi T; Tyagi P; Mizoguchi S; Saito T; Furuta A; Suzuki Y; Egawa S; Wang Z; Yoshimura N
Prostate; 2021 Dec; 81(16):1303-1309. PubMed ID: 34596255
[TBL] [Abstract][Full Text] [Related]
14. Effect of Intravesical Liposome-Based Nerve Growth Factor Antisense Therapy on Bladder Overactivity and Nociception in a Rat Model of Cystitis Induced by Hydrogen Peroxide.
Majima T; Tyagi P; Dogishi K; Kashyap M; Funahashi Y; Gotoh M; Chancellor MB; Yoshimura N
Hum Gene Ther; 2017 Jul; 28(7):598-609. PubMed ID: 28446032
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of nerve growth factor expression in the bladder by antisense oligonucleotides as new treatment for overactive bladder.
Kashyap M; Kawamorita N; Tyagi V; Sugino Y; Chancellor M; Yoshimura N; Tyagi P
J Urol; 2013 Aug; 190(2):757-64. PubMed ID: 23454160
[TBL] [Abstract][Full Text] [Related]
16. Bladder overactivity and afferent hyperexcitability induced by prostate-to-bladder cross-sensitization in rats with prostatic inflammation.
Funahashi Y; Takahashi R; Mizoguchi S; Suzuki T; Takaoka E; Ni J; Wang Z; DeFranco DB; de Groat WC; Tyagi P; Yoshimura N
J Physiol; 2019 Apr; 597(7):2063-2078. PubMed ID: 30666643
[TBL] [Abstract][Full Text] [Related]
17. Liposome Based Intravesical Therapy Targeting Nerve Growth Factor Ameliorates Bladder Hypersensitivity in Rats with Experimental Colitis.
Kawamorita N; Yoshikawa S; Kashyap M; Tyagi P; Arai Y; Chancellor MB; Yoshimura N
J Urol; 2016 Jun; 195(6):1920-6. PubMed ID: 26780168
[TBL] [Abstract][Full Text] [Related]
18. Nerve growth factor (NGF): a potential urinary biomarker for overactive bladder syndrome (OAB)?
Seth JH; Sahai A; Khan MS; van der Aa F; de Ridder D; Panicker JN; Dasgupta P; Fowler CJ
BJU Int; 2013 Mar; 111(3):372-80. PubMed ID: 23444927
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
